~67% of people who inject drugs are infected with HCV

~20% to 30% are infected with HCV within the first two years of injecting drugs

Location and Time

Saturday, April 8, 2017
Program begins at 6:30 pm
Dinner served

Room Grand Salon C
Hilton New Orleans Riverside
Two Poydras Street
New Orleans, LA

HCV is the most common chronic blood-borne infection in the US.

Stories are part of being human; they’re the way we organize our brains. This is why the famous TED talks appeal to millions of people; they employ our most potent tools of memory and imagination to expand our minds.

DKBmed Talks now bring this engaging format to health care providers. Our expert faculty share their most poignant stories – the patients who made them appreciate why they chose to practice medicine. In addition, all the scientific and clinical details will be provided in a way you have never seen before.

Meet Theresa and hear how we will tackle:

  • Screening patients in the addiction care setting
  • Analyzing barriers
  • Adherence
  • Preventing HCV reinfection
  • New direct-acting antivirals (DAAs)
  • Therapies in development
  • Individualizing therapy for PWIDs

Registration for this meeting is now closed, but there are still seats available!

Please arrive at Grand Salon C by 6:30pm.



Theresa - A DKBmed Talk Part 1

Faculty Presentation:

  • USPSTF Screening Recommendations
  • Screening Patients in the Addiction Center Setting – What to Look For
  • Beyond the Biopsy: New Methods for HCV Testing

Theresa - A DKBmed Talk Part 2

Faculty Presentation:

  • Analyzing Barriers: What’s Fact and What’s Fiction?
  • Addressing Adherence: Keeping High-Risk Patients on the Right Track
  • Preventing Reinfection Through Effective Patient Counseling and Education

Theresa - A DKBmed Talk Part 3

Faculty Presentation:

  • Benefits of Newer Therapies: Reduced CKD, Renal Toxicity, and Bone Loss
  • Creating Achievable Goals with Single-Pill Regimens
  • The Importance of Minimizing Adverse Events

Audience Q&A


  • Mark S. Sulkowski, MD

    Professor of Medicine
    Medical Director, Viral Hepatitis Center
    Divisions of Infectious Diseases and Gastroenterology/Hepatology
    Johns Hopkins University School of Medicine
    Baltimore, Maryland


  • Kathleen T. Brady, M.D., Ph.D.

    Distinguished University Professor
    Vice President for Research
    Director, South Carolina Clinical and Translational Research Institute
    Medical University of South Carolina
    Charleston, South Carolina